Variant report
Variant | nsv913351 |
---|---|
Chromosome Location | chr21:14539073-14669931 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142211526 | chr21:14619600-14619601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113971599 | chr21:14619616-14619617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141460135 | chr21:14619650-14619651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184749096 | chr21:14619666-14619667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2997012 | chr21:14619682-14619683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2997013 | chr21:14619696-14619697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543406096 | chr21:14619697-14619698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs146970651 | chr21:14619767-14619768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201232074 | chr21:14619783-14619784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs202154830 | chr21:14619837-14619838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545571809 | chr21:14619871-14619872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2334427 | chr21:14619876-14619877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528655743 | chr21:14619880-14619881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548508032 | chr21:14619883-14619884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374289918 | chr21:14619890-14619891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568383164 | chr21:14619895-14619896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200381343 | chr21:14619920-14619921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530837093 | chr21:14619935-14619936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550516159 | chr21:14619961-14619962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532816383 | chr21:14620000-14620001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2997014 | chr21:14620026-14620027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150232205 | chr21:14620043-14620044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2259468 | chr21:14620054-14620055 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs565892189 | chr21:14620059-14620060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559337326 | chr21:14620075-14620076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534795007 | chr21:14620104-14620105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528051472 | chr21:14620140-14620141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374908395 | chr21:14620165-14620166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574755775 | chr21:14620201-14620202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552388077 | chr21:14620216-14620217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369683207 | chr21:14620224-14620225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs537045264 | chr21:14620240-14620241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373112936 | chr21:14620276-14620277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144688074 | chr21:14620278-14620279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576761000 | chr21:14620279-14620280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545912476 | chr21:14620318-14620319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559168018 | chr21:14620320-14620321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573119240 | chr21:14620348-14620349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2259427 | chr21:14620359-14620360 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs112689261 | chr21:14667211-14667212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192535622 | chr21:14667227-14667228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560316770 | chr21:14667233-14667234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7275943 | chr21:14667238-14667239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142040374 | chr21:14667240-14667241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562798966 | chr21:14667242-14667243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145899499 | chr21:14667254-14667255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551435107 | chr21:14667270-14667271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528259434 | chr21:14667296-14667297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568604593 | chr21:14667367-14667368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184922724 | chr21:14667414-14667415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:14619600-14620400 | Enhancers | Brain Hippocampus Middle | brain |
2 | chr21:14667200-14668400 | Enhancers | Brain Hippocampus Middle | brain |